Monday, September 17, 2012

Bioethics at MTSU

New Course, Spring 2013
Philosophy 3345 – Bioethics
Mondays & Wednesdays, 2:20-3:45, Peck Hall 220
This course explores ethical issues arising from the practice of medical therapeutics (conventional and “alternative”), from the development of new biomedical technologies, and more largely from reflections on life’s meaning and prospects. 

     The course aims at clarifying relevant bioethical and medical issues and debates, representing various perspectives in application to present and future human possibilities and concerns (for example: genetic engineering and biochemical “enhancement,” longevity and life extension, end-of-life decisions, health care access, nanotechnology, cloning, stem cell research, mood and performance-enhancing pharmaceutical use, animal research, and reproductive technologies). 

        We’ll also explore the future of life (human, nonhuman, and trans- or post-human).

The course’s ultimate objective is to provide students with critical resources and tools they can apply in making crucial life-choices.

“Bio” means simply life, but questions about life’s goals, about appropriate means for attaining them, and about the professions devoted to sustaining life, give rise to the most basic, enduring, and fascinating ethical problems and prospects.

Primary text:


Bioethics for Beginners60 Cases and Cautions from the Moral Frontier of Healthcare maps the giant dilemmas posed by new technologies and medical choices, using 60 cases taken from the headlines, and from the worlds of medicine and science… shedding light on the social, economic and legal side of 21st century medicine while giving the reader an informed basis on which to answer personal, practical questions and decide for themselves exactly what the scientific future should hold.” [NOTE: Kindle edition available]

Course website: Bioethics - Supporting the philosophical study of bioethics, bio-medical ethics, biotechnology, and the future of life, at Middle Tennessee State University and beyond...

For more info, contact Dr. Phil Oliver,

No comments: Accelerating Intelligence News